In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd
In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd

In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd

We anticipate stronger growth through our upcoming product launches in domestic and export markets, improved operational efficiency, and the introduction of higher-margin products, articulates Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd.

DSIJ Intelligence Article rating: 4.3

We anticipate stronger growth through our upcoming product launches in domestic and export markets, improved operational efficiency, and the introduction of higher-margin products, articulates Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd.

DSIJ MINDSHARE

Mkt Commentary30-Apr, 2025

Penny Stocks1-May, 2025

IPO1-May, 2025

Multibaggers1-May, 2025

Mindshare30-Apr, 2025

Knowledge

MF30-Apr, 2025

Knowledge29-Apr, 2025

MF22-Apr, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR